Search alternatives:
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), use decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), use decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
4961
-
4962
-
4963
-
4964
-
4965
-
4966
Image_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF
Published 2018“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
-
4967
Image_2_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF
Published 2018“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
-
4968
Table_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.DOCX
Published 2018“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
-
4969
B-factor values of Ca<sub>V</sub>3.3 M1425 substitutions.
Published 2025“…Previously, we established <i>CACNA1I</i>, the gene coding for Ca<sub>V</sub>3.3, as a disease gene for neurodevelopmental disease with or without epilepsy. …”
-
4970
Table_4_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX
Published 2020“…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …”
-
4971
Table_1_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX
Published 2020“…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …”
-
4972
Table_2_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX
Published 2020“…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …”
-
4973
-
4974
-
4975
-
4976
-
4977
-
4978
Trend coefficients and AUC statistics across four control populations (“Pop’n 1” to “Pop’n 4”) and four warming populations (“Pop’n 5” to “Pop’n 8”), as calculated from empirical time series during the approach to criticality. Each statistical metric was calculated within fifteen-day sliding windows, throughout the pre-critical interval. Given that the temperature of the system increased to 12°C on day sixty, we also considered three pre-critical intervals: Days 1 to 60, Days 20 to 60, and Days 30 to 60. Here, we show analyses of empirical time series performed within the sixty-day pre-critical interval....
Published 2025“…Here, we show analyses of empirical time series performed within the sixty-day pre-critical interval. …”
-
4979
-
4980
In the absence of chloride, two-fold decrease in [Na<sup>+</sup>]<sub>e</sub> shifted GLT-1a E<sub>rev</sub> by −28 mV at both low and high glutamate concentrations.
Published 2015“…Arrows show amplitudes and directions of E<sub>rev</sub> shifts associated with decrease in [Na<sup>+</sup>]<sub>e</sub>. <b>(D)</b> Average E<sub>rev</sub> shifts at [Glu<sup>-</sup>]<sub>e</sub> geometric means of 37.5 and 600 μM are approximately equal when [Na<sup>+</sup>]<sub>e</sub> was decreased from 102 to 51 mM. …”